Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Dawn Waterhouse

A Low Carbohydrate, High Protein Diet Slows Tumor Growth and Prevents Cancer Initiation

scientific article published on 14 June 2011

A novel combination of Chinese medicines to treat advanced cancers and lymphomas in rats

article

A novel liposomal irinotecan formulation with significant anti-tumour activity: use of the divalent cation ionophore A23187 and copper-containing liposomes to improve drug retention.

scientific article published on 2 September 2007

Determination of an optimal dosing schedule for combining Irinophore C™ and temozolomide in an orthotopic model of glioblastoma.

scientific article published on 31 October 2015

Drug-drug interactions arising from the use of liposomal vincristine in combination with other anticancer drugs

scientific article published on September 1, 2001

HER-2/neu overexpression increases the viable hypoxic cell population within solid tumors without causing changes in tumor vascularization.

scientific article published in November 2004

Irinophore C: a liposome formulation of irinotecan with substantially improved therapeutic efficacy against a panel of human xenograft tumors.

scientific article

Irinophore C™, a lipid nanoparticle formulation of irinotecan, abrogates the gastrointestinal effects of irinotecan in a rat model of clinical toxicities

scientific article

Irinophore C™, a lipid nanoparticulate formulation of irinotecan, improves vascular function, increases the delivery of sequentially administered 5-FU in HT-29 tumors, and controls tumor growth in patient derived xenografts of colon cancer

scientific article published on 8 December 2014

Irinophore C™, a lipid-based nanoparticulate formulation of irinotecan, is more effective than free irinotecan when used to treat an orthotopic glioblastoma model.

scientific article published on 5 October 2011

Lipid-based nanoformulation of irinotecan: dual mechanism of action allows for combination chemo/angiogenic therapy

scientific article published on 01 November 2011

Liposomal irinotecan: formulation development and therapeutic assessment in murine xenograft models of colorectal cancer.

scientific article

Modulation of cancer cell survival pathways using multivalent liposomal therapeutic antibody constructs

scientific article published on 05 March 2007

Nanotheraputics ⬇️

scientific article published on March 21, 2013

Pharmacodynamic behavior of liposomal antisense oligonucleotides targeting Her-2/neu and vascular endothelial growth factor in an ascitic MDA435/LCC6 human breast cancer model.

scientific article published on February 2004

Plasma protein binding, lipoprotein distribution and uptake of free and lipid-associated BCL-2 antisense oligodeoxynucleotides (G3139) in human melanoma cells.

scientific article

Preparation, Characterization, and Biological Analysis of Liposomal Formulations of Vincristine

article

Retraction. A novel combination of Chinese medicines to treat advanced cancers and lymphomas tested in rats

scientific article published on 16 March 2010

Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of integrin-linked kinase (ILK).

scientific article

Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.

scientific article published on 17 March 2011

Temporal targeting in cancer: combined chemotherapy and antiangiogenic therapy

scientific article published on 01 October 2006

The liposomal formulation of doxorubicin

scientific article

The role of the transition metal copper and the ionophore A23187 in the development of Irinophore C™

scientific article published on 23 December 2010

Topophore C: a liposomal nanoparticle formulation of topotecan for treatment of ovarian cancer ⬇️

scientific article published on May 22, 2012

Treatment of Colorectal Cancer Using a Combination of Liposomal Irinotecan (Irinophore C™) and 5-Fluorouracil ⬇️

scientific article published on April 23, 2013

Validating the use of a luciferase labeled breast cancer cell line, MDA435LCC6, as a means to monitor tumor progression and to assess the therapeutic activity of an established anticancer drug, docetaxel (Dt) alone or in combination with the ILK inh

scientific article

Vascular normalization in orthotopic glioblastoma following intravenous treatment with lipid-based nanoparticulate formulations of irinotecan (Irinophore C™), doxorubicin (Caelyx®) or vincristine

scientific article

Paulina is supported by:

About Paulina

Help